ESC 365 - Blood pressure, glycemic, and cholesterol control among adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2023

ESC2025 Premium Access

Blood pressure, glycemic, and cholesterol control among adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2023

Session: Cardiometabolic diseases (1)

Topic: Epidemiology

Speaker: Doctor J. Gong (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jingyi Gong

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

0 follower

7 more presentations in this session

Comparison of nutritional risk scores for predicting cardiovascular morbidity and mortality in incident haemodialysis patients

Speaker: Assistant Professor H. Takahashi (Toyoake, JP)

Cardiovascular disease burden attributable to decreased estimated glomerular filtration rate: insights from the ATTICA study (2002-2022)

Speaker: Miss E. Damigou (Athens, GR)

Impact of cardiometabolic index on cardiovascular-kidney-metabolic syndrome stage progression: a nationwide prospective cohort study

Speaker: Miss S. Wu (Beijing, CN)

Impact of body mass index and prediabetes on the risk of type 2 diabetes and cardiovascular events following a recent myocardial infarction

Speaker: Doctor P. Tonnesen (Aarhus, DK)

Associations of metabolic vulnerability index with cardiometabolic diseases, multimorbidity, and all-cause mortality

Speaker: Doctor S. Zhu (Hangzhou, CN)

Access the full session

Cardiometabolic diseases (1)

Speakers: Doctor J. Gong, Assistant Professor H. Takahashi, Miss E. Damigou, Miss S. Wu, Doctor P. Tonnesen...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources